VEGFA and age-related macular degeneration: Our results correspond with those from post-hoc analyses of the Comparison of AMD Treatment Trial (CATT) and the Inhibition of VEGF in Age-Related Choroidal Neovascularization (IVAN) randomized clinical trial showing that large variations in foveal thickness complicating nAMD treatment were associated with worse BCVA and the development of fibrosis.5